Viewing Study NCT06779695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2026-02-02 @ 3:52 PM
Study NCT ID: NCT06779695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-16
First Post: 2025-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)
Sponsor: Korea University Anam Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atrial Fibrillation (AF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Apixaban, View
None Rivaroxaban View